26 . May , 2019 - Sunday
Check todays hot topics or new products

Find a Drug: Advanced

Please Sign in or Register

All about: Cytarabine Liposomal

Big Image Pronouncation: (SITE-ah-rah-been)
Class: Pyrimidine analog

Trade Names:
DepoCyt
- Suspension equivalent to 10 mg/mL cytarabine

Mechanism of Action

Pharmacology

Cytarabine exhibits cell-phase specificity, primarily killing cells undergoing DNA synthesis (S-phase) and under certain conditions, blocking the progression of cells from the G 1 phase to the S-phase.

Pharmacokinetics

Absorption

T max is within 5 h for free cytarabine in both the ventricle and the lumbar sac.

Metabolism

Intracellularly converted to cytarabine-5′-triphosphate (ara-CTP), which is the active metabolite. Metabolism to ara-U (inactive) is primary route of elimination.

Elimination

ara-U is excreted in the urine. Biphasic elimination; terminal t ½ is 100 to 263 h (12.5 to 75 mg).

Indications and Usage

Adult

Lymphomatous meningitis.

Contraindications

Active meningeal infection hypersensitivity to cytarabine or any other ingredient in the formulation.

Dosage and Administration

Liposomal Cytarabine Dose

The dose of liposomal cytarabine is different from the dose of conventional cytarabine.

Induction Therapy Adults

Intrathecally 50 mg every 14 days for 2 doses, during weeks 1 and 3.

Consolidation Therapy Adults

Intrathecally 50 mg every 14 days for 3 doses, during weeks 5, 7, and 9. Then, give an additional 50 mg dose during week 13.

Maintenance Regimen Adults

Intrathecally 50 mg every 28 days for 4 doses, during weeks 17, 21, 25, and 29.

Dosage Adjustment for Neurologic Toxicity Adults

Intrathecally If neurologic toxicity occurs, reduce the dose to 25 mg. Discontinue if toxicity persists.

Pretreatment Regimen Adults

Intrathecally To reduce the incidence of chemical arachnoiditis, treat all patients with 4 mg dexamethasone orally or IV twice daily for 5 days starting the day of liposomal cytarabine administration. Inject via an intraventricular reservoir or directly into the lumbar sac. The patient should lie flat for at least 1 h after the injection. Do not use in-line filters.

General Advice

  • Warm the vial to room temperature. Gently swirl or invert the vial to suspend the particles.
  • Do not dilute.
  • Liposomal cytarabine is preservative-free. Use the suspension within 4 h after removing it from the vial.
  • Administer by intrathecal injection over 1 to 5 min.

Storage/Stability

Refrigerate unopened vials; do not freeze. Avoid shaking vials vigorously. Unopened vials are stable at room temperature for up to 72 h.

Drug Interactions

Antineoplastics

Coadministration may increase the risk of neurotoxicity.

Gentamicin

Gentamicin effectiveness against Klebsiella pneumoniae strains may be decreased.

Laboratory Test Interactions

Because liposomal cytarabine particles are similar in size and appearance to white blood cells, take care in interpreting CSF examinations following liposomal cytarabine administration.

Adverse Reactions

CNS

Headache; asthenia; confusion; somnolence; Transient elevations in CSF protein and WBC; encephalopathy; gait disturbance; neurotoxicity; meningismus; paresthesia.

GI

Nausea; vomiting; constipation.

Hematologic

Neutropenia; thrombocytopenia.

Musculoskeletal

Myelopathy; back pain; pain.

Miscellaneous

Chemical arachnoiditis syndrome; nausea; vomiting; headache; fever; neck rigidity; neck pain; meningismus; back pain; CSF pleocytosis.

Precautions

Monitor

Bone marrow examinations

During induction therapy, perform leukocyte and platelet counts daily. Perform bone marrow examinations frequently after blasts have disappeared from the peripheral blood.

Drug-induced marrow depression

Suspend or modify therapy when drug-induced marrow depression results in a platelet count less than 50,000/mm 3 or a polymorphonuclear granulocyte count less than 1,000/mm 3 .


Pregnancy

Category D .

Children

Safety and efficacy have not been established.

Hypersensitivity

Cases of anaphylaxis have occurred resulting in acute cardiopulmonary arrest which required resuscitation. This occurred immediately after IV administration.

Renal Function

Patients with renal function impairment may have a higher likelihood of CNS toxicity after high-dose cytarabine. Use the drug with caution and possibly at reduced doses in patients with poor kidney function.

Hepatic Function

Patients with hepatic function impairment may have a higher likelihood of CNS toxicity after high-dose cytarabine. Use the drug with caution and possibly at reduced doses in patients with poor hepatic function.

Chemical arachnoiditis

A syndrome manifested primarily by nausea, vomiting, headache, and fever has been a common adverse reaction in all studies. If left untreated, chemical arachnoiditis may be fatal. The incidence and severity of chemical arachnoiditis can be reduced by coadministration of dexamethasone.

CSF examination interpretation

Liposomal cytarabine particles and white blood cells are similar in appearance and size. Use caution when interpreting CSF examinations after administration of liposomal cytarabine.

Extravasation risk

Liposomal cytarabine is an irritant and can cause local irritation or phlebitis. Refer to your institution specific protocol.

Infection

Viral, bacterial, fungal, parasitic, or saprophytic infections in any location in the body may be associated with the use of cytarabine alone or in combination with other immunosuppressive agents.

Intrathecal use

If used intrathecally, do not use a diluent with benzyl alcohol.

Myelosuppression/Hematologic

Anemia, leukopenia, thrombocytopenia, megaloblastosis, and reduced reticulocytes can be expected. The severity of these reactions is dose- and schedule-dependent.

Neuropathies

Peripheral motor and sensory neuropathies have occurred.

Neurotoxicity

Enhanced neurotoxicity has been associated with concurrent use of intrathecal cytarabine and other cytotoxic agents administered intrathecally. Monitor neurologic function at baseline and periodically throughout treatment.

Patient Information

  • Inform patients about the expected adverse reactions of headache, nausea, vomiting and fever, and about the early signs and symptoms of neurotoxicity.
  • Emphasize the importance of dexamethasone coadministration at the initiation of each cycle of liposomal cytarabine treatment. Instruct patients to seek medical attention if signs or symptoms of neurotoxicity develop, or if oral dexamethasone is not well tolerated.

Recent Drug Updates at DrugIndexOnline:





Boniva Boniva
Generic Name: ibandronate sodium Dosage Form: Injection Boniva Description Boniva (ibandronate sodium) is a nitrogen-containing bisphosphonate that inhibits osteoclast-mediated bone resorption. The chemical name for ibandronate sodium is 3-(N-methyl-N-pentyl)amino-1-hydroxypropane-1,1-diphosphoni more...

flax flax
Generic Name: flax (FLACKS) Brand Names: What is flax? The use of flax in cultural and traditional settings may differ from concepts accepted by current Western medicine. When considering the use of herbal supplements, consultation with a primary health care professional is advisable. A more...

Fostex Regular Strength Medicated Cover-Up Topical Fostex Regular Strength Medicated Cover-Up Topical
Some commonly used brand names are: In the U.S.— Cuticura Ointment Finac Fostex Regular Strength Medicated Cover-Up Fostril Lotion Lotio Alsulfa Sulpho-Lac In Canada— Fostex CM Fostril Cream Generic name product may be available in the U.S. and Canada. Category Antiacne agent more...

Indomethacin Indomethacin
Dosage Form: Capsules Rx only Cardiovascular Risk NSAIDs may cause an increased risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke, which can be fatal. This risk may increase with duration of use. Patients with cardiovascular disease or risk factors for card more...

Levobunolol Levobunolol
Pronouncation: (LEE-voe-BYOO-no-lahl) Class: Beta-adrenergic blocking agent, Ophthalmic Trade Names: AK-Beta - Solution 0.25% - Solution 0.5% Trade Names: Betagan Liquifilm - Solution 0.25% - Solution 0.5% Apo-Levobunolol (Canada) Betagan (Canada) Novo-Levobunolol (Canada) PMS-Levobunolol (Canada) more...

Loprox Topical Suspension Loprox Topical Suspension
Generic Name: ciclopirox Dosage Form: Topical suspension FOR DERMATOLOGIC USE ONLY.NOT FOR USE IN EYES. Rx Only Loprox Description Loprox® Topical Suspension (ciclopirox) 0.77% is for topical use. Each gram of Loprox® Topical Suspension contains 7.70 mg of ciclopirox (as ciclopirox olam more...

PC-CAP PC-CAP
Generic Name: aspirin/caffeine/propoxyphene (AS pir in/CAF feen/proe POX ih feen) Brand Names: Darvon Compound 32, Darvon Compound-65, PC-CAP, Propoxyphene Compound 65 What is PC-CAP (aspirin/caffeine/propoxyphene)? Propoxyphene (related to codeine) is in a class of drugs called narcoti more...

Penicillin G Sodium Penicillin G Sodium
Generic Name: Penicillin G Sodium Injection (pen-i-SILL-in G soe-dee-uhm) Brand Name: Generic only. No brands available.Penicillin G Sodium is used for:Treating some types of infections caused by certain bacteria. Penicillin G Sodium is a penicillin antibiotic. It works by interfering with the more...